SCHEMBL19086684

SCHEMBL19086684

COC(=O)c1c(O)c2cc(C(=O)N(C)C(c3ccccc3)c3ccccc3)ccc2n(C)c1=O

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.73
L3MBTL1 Q9Y468 2/20 0.45
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
PGR P06401 1/20 0.45
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 3/20 0.41
ALOX15 P16050 1/20 0.41
GAA P10253 1/20 0.40
RAB9A P51151 2/20 0.40
NLRP3 Q96P20 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
EGFR P00533 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17578572 0.85 HIF1A (1.00) HIF1AMEN1KMT2ANPC1RAB9A
SCHEMBL19086545 0.82 HIF1A (0.52) HIF1AL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL19086664 0.74 HIF1A (0.71) HIF1AALDH1A1KDM4EGAA
SCHEMBL1685954 0.74 ALDH1A1 (0.72) L3MBTL1MEN1KMT2APGRALDH1A1
SCHEMBL19086870 0.74 NPC1 (0.53) HIF1AMEN1KMT2AALDH1A1KDM4E
SCHEMBL19086606 0.72 ALDH1A1 (0.57) HIF1AMEN1KMT2AALDH1A1KDM4E
SCHEMBL2545775 0.72 ALDH1A1 (0.66) L3MBTL1MEN1KMT2APGRALDH1A1
SCHEMBL19086548 0.70 HIF1A (0.71) HIF1AALDH1A1KDM4EGAA
SCHEMBL10676697 0.70 MEN1 (0.74) L3MBTL1MEN1KMT2APGRALDH1A1
SCHEMBL19086549 0.69 RAB9A (0.51) HIF1AL3MBTL1MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190104-B1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-10-27 EP disclosed
US-10065928-B2 Quinolinone compound and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-09-04 US disclosed
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-08-31 US disclosed
EP-3190104-A1 QUINOLINONE COMPOUND AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF HIF1AN, HIF1A, EGLN2 HIF1A 2/4885L3MBTL1 4028/4885MEN1 3273/4885
US-10065928-B2 Quinolinone compound and use thereof HIF1AN, HIF1A, EGLN2 HIF1A 2/4885L3MBTL1 4028/4885MEN1 3273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.